AFMD
Affimed NV
Price:  
0.59 
USD
Volume:  
571,902.00
Germany | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AFMD EV/EBITDA

-1581.4%
Upside

As of 2024-02-29, the EV/EBITDA ratio of Affimed NV (AFMD) is -0.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AFMD's latest enterprise value is 42.95 mil USD. AFMD's TTM EBITDA according to its financial statements is -111.44 mil USD. Dividing these 2 quantities gives us the above AFMD EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 5.9x - 12.2x 9.0x
Forward P/E multiples 11.8x - 14.9x 13.4x
Fair Price (9.22) - (9.55) (8.74)
Upside -1663.6% - -1718.3% -1581.4%
0.59 USD
Stock Price
(8.74) USD
Fair Price

AFMD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-28 -0.36
2024-02-27 -0.35
2024-02-26 -0.32
2024-02-23 -0.28
2024-02-22 -0.29
2024-02-21 -0.28
2024-02-20 -0.31
2024-02-16 -0.37
2024-02-15 -0.34
2024-02-14 -0.35
2024-02-13 -0.34
2024-02-12 -0.36
2024-02-09 -0.30
2024-02-08 -0.28
2024-02-07 -0.31
2024-02-06 -0.32
2024-02-05 -0.27
2024-02-02 -0.31
2024-02-01 -0.32
2024-01-31 -0.31
2024-01-30 -0.29
2024-01-29 -0.32
2024-01-26 -0.33
2024-01-25 -0.34
2024-01-24 -0.33
2024-01-23 -0.35
2024-01-22 -0.34
2024-01-19 -0.36
2024-01-18 -0.37
2024-01-17 -0.36
2024-01-16 -0.39
2024-01-12 -0.41
2024-01-11 -0.45
2024-01-10 -0.42
2024-01-09 -0.43
2024-01-08 -0.44
2024-01-05 -0.39
2024-01-04 -0.44
2024-01-03 -0.35
2024-01-02 -0.40
2023-12-29 -0.40
2023-12-28 -0.29
2023-12-27 -0.21
2023-12-26 -0.19
2023-12-22 -0.18
2023-12-21 -0.19
2023-12-20 -0.09
2023-12-19 -0.12
2023-12-18 -0.12
2023-12-15 -0.10